ResMed, Inc. (RMD)

228.12 +3.40 (+1.51%) USD  |  NYSE  |  Apr 17, 16:00
228.05 -0.07 (-0.03%) Pre-Market: 20:00
More

ResMed SG&A Expense (Quarterly) : 278.40M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 1.834B
Abbott Laboratories 3.74B
Baxter International, Inc. 761.00M
Globus Medical, Inc. 318.48M
Intuitive Surgical, Inc. 687.10M